Barrueco M, Otero M J, Garcia M J, Lanao J M, Dominguez-Gil A
Int J Clin Pharmacol Ther Toxicol. 1986 Sep;24(9):485-9.
The pharmacokinetics of cefoxitin was studied in 14 patients with a pleural effusion, 8 of which had normal renal function and the other 6 varying degrees of renal impairment. All patients received a single dose of 30 mg/kg i.v. bolus of the antibiotic. The serum and pleural fluid concentrations of cefoxitin were determined microbiologically. The serum elimination half-life of the antibiotic in the group of patients with normal renal function had a mean value of 1.35 +/- 0.56 h while that of the second group ranged between 2.00 h and 40.79 h, according to the deterioration in renal function. The disappearance half-life of cefoxitin from pleural fluid increased parallel to the degree of renal impairment, reaching a value of 30.09 h for a creatinine clearance (Ccr) of 5.8 ml/min. From the data obtained, dosage regimens were programmed according to the degree of renal function with the aim of achieving safe and efficient cefoxitin levels in both biological fluids.
对14例胸腔积液患者的头孢西丁药代动力学进行了研究,其中8例肾功能正常,另外6例有不同程度的肾功能损害。所有患者均静脉推注单剂量30mg/kg的该抗生素。采用微生物学方法测定头孢西丁的血清和胸腔积液浓度。肾功能正常患者组中该抗生素的血清消除半衰期平均值为1.35±0.56小时,而第二组根据肾功能损害程度,其半衰期在2.00小时至40.79小时之间。头孢西丁在胸腔积液中的消除半衰期随肾功能损害程度平行增加,当肌酐清除率(Ccr)为5.8ml/min时达到30.09小时。根据获得的数据,根据肾功能程度制定给药方案,目的是在两种生物体液中达到安全有效的头孢西丁水平。